Vuno Inc. (338220.KQ)
KOSDAQ · KRW · Healthcare · Health Information Services
₩7,030 (-8.46%) as of
Key statistics
- Market cap
- 98.43B
- Dividend yield
- 0.00%
- 52-week range
- 4,235.00 – 28,350.00
- Beta
- 0.94
- Revenue (TTM)
- 30.22B
- Profit margin
- -36.56%
- Volume
- 852.46k
About Vuno Inc.
Vuno Inc. engages in the artificial intelligence medical software development and services business. The company provides medical AI solutions for analyzing various medical data and assisting in disease diagnosis. It also offers BoneAge, an AI diagnostic software for bone age assessment; DeepBrain, a brain parcellation for the quantitative analysis of neurodegenerative diseases and other neurological disorders; chest X-ray, a diagnostic support system for abnormalities in chest x-ray; fundus AI, an AI-based screening solution for various abnormalities in the fundus of the eye; DeepCARS, an AI-based cardiac arrest risk management system; and LungCT AI, an AI-based pulmonary lung nodule detection and reporting system. In addition, the company provides medical products under HATIV brand, such as HATIV K30, a kiosk-type medical device that measures electrocardiograms; HATIV P30, a medical ECG device; HATIV BP30, an automatic blood pressure monitoring device; and HATIV TP50T, an ear infrared thermometer device. The company was founded in 2014 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Seoul, South Korea
- Employees
- 146
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.